Abstract: BACKGROUND: Dermal fibroblasts from patients with systemic sclerosis (SSc) release excessive amounts of collagen resulting in tissue fibrosis. The molecular mechanisms underlying this pathological activation are incompletely understood. OBJECTIVE: To investigate whether Notch signalling contributes to the uncontrolled activation of fibroblasts in SSc. METHODS: Activation of the Notch pathway was assessed by immunohistochemistry or Western blot for the Notch intracellular domain and the Notch ligand Jagged-1 (Jag-1) and real-time PCR for the target gene hes-1. Differentiation of resting dermal fibroblasts into myofibroblasts was assessed by staining for -smooth muscle actin. The synthesis of collagen was quantified by real-time PCR and Sircol assays. RESULTS: Notch signalling was activated in lesional skin of patients with SSc. The activation persisted in cultured dermal SSc fibroblasts. Stimulation of healthy dermal fibroblasts with recombinant human Jag-1-Fc chimera resulted in an SSc-like phenotype with increased release of collagen and differentiation of resting fibroblasts into myofibroblasts. Consistent with the selective activation of the Notch pathway in dermal SSc fibroblasts, DAPT or siRNA against Notch strongly reduced the basal collagen expression in SSc fibroblasts, but not in fibroblasts from healthy volunteers. CONCLUSION: It was shown that Notch signalling is activated in SSc and plays an important role in fibroblast activation and collagen release. Inhibition of Notch signalling might be an effective strategy to selectively prevent the aberrant activation of SSc fibroblasts. 
Introduction
The major histopathologic hallmark of SSc is an excessive accumulation of extracellular matrix proteins. [1, 2] The molecular mechanisms underlying the pathologic activation of SSc fibroblasts have only partially been elucidated.
Notch signaling, first discovered in Drosophila, is essential for cell fate decision and development. [3, 4] Activation of the Notch pathway by binding of ligands such as Jagged-1 (Jag-1) results in cleavage of Notch receptors by the γ-secretase complex with subsequent release of the active Notch intracellular domain (NICD). [3] Two families of canonical Notch ligands have been described (Jagged and Delta-like), which seem to have distinct function. [5, 6] As described for T helper cell differentiation, Jagged induces Th2 response, whereas Deltalike, mainly Dll-4, is responsible for Th1 differentiation. [5] These ligands can interact with Notch receptors on both the surface of another cell (trans-interaction) and of the same cell (cis-interaction). [6] In contrast to the trans-interaction, cis-interactions seem to inhibit Notch signaling. The mechanisms and effects of cis-interactions, however, are still unkown. [6] In addition to the canonical ligands, several non-canonical ligands such as CCN3, MAGP-1 and MAGP-2 have been described. [6] Translocation of the NICD into the nucleus activates the transcription of target genes such as the Hairy/Enhancer of Split (Hes). [7] Alterations in Notch signaling are implicated in the pathogenesis of several human diseases such as T cell acute lymphoblastic leukemia (T-ALL), melanoma and Alagille syndrome. [8] [9] [10] [11] Clinical trials with γ-secretase inhibitors in patients with T-ALL already yielded promising results. [12] The present study aimed to investigate whether Notch signaling may promote fibroblast activation and persistently increased release of collagen in SSc. 4 
Material and Methods

Fibroblast cultures
Dermal fibroblast cultures were obtained from skin biopsies of SSc patients. All patients fulfilled the criteria for SSc as suggested by LeRoy et al. [13] Biopsies from SSc patients (n = 10) were taken from involved skin of the forearm (supplementary Table 1 ).
Control dermal fibroblasts (n = 10) were obtained from forearm skin biopsies of healthy ageand sex-matched volunteers. Dermal fibroblasts from passages 4-8 were used for the experiments. All patients and controls signed a consent form approved by the local institutional review boards.
Stimulation of dermal fibroblasts with Jag-1 and inhibition of Notch signaling
Confluent dermal fibroblasts were cultured in DMEM containing 0.1 % FCS for 24 h before the experiments. Dermal fibroblasts were stimulated with recombinant human Jag-1 Fc Chimera (R&D Systems, Minneapolis, MN, USA) dissolved in PBS in concentrations from 0.04 to 5.0 µg/ml for 24 h.
To assess the effects of Notch signaling inhibition, dermal fibroblasts were incubated with the γ-secretase inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine tbutyl ester (DAPT) (Sigma-Aldrich, Steinheim, Germany) at concentrations of 1.0 and 10 µM for 24 h. Jag-1 was added one hour after DAPT at a concentration of 5.0 µg/ml.
In addition to DAPT, dermal SSc fibroblasts were transfected with 1.5 µg siRNA against Notch-1 using the human dermal fibroblast Nucleofector Kit (Amaxa, Cologne, Germany) (supplementary Table 2 ). [14] Fibroblasts transfected with control siRNA (Ambion, Darmstadt, Germany) served as controls. Cells were harvested after 48 h. 5 To investigate whether Jag-1 stabilizes collagen mRNA, mRNA-stability assay was performed as previously described. [15] Luciferase reporter assay
mRNA-stability assay
The -353 col1a2 / luciferase construct was kindly provided by M. Trojanowska. [15] HEK293T cells were transfected in serum-free medium with 0.5 µg reporter construct mixed with polyethyleneimine (PEI). A common lacZ reporter vector was used as control. Cells were stimulated with Jag-1 directly after the transfection. The luciferase activity was analyzed after 24 h.
Quantitative real time PCR
Total RNA was isolated with the NucleoSpin RNA II extraction system (MacheryNagel, Düren, Germany) and converted into cDNA as described. [16] In skin samples, the epidermal and dermal layers were separated for RNA isolation. The primer pairs used for realtime PCR are given in Supplementary Table 2. A pre-developed β-actin assay (Applied Biosystems) was used to normalize for the amounts of loaded cDNA. All samples were measured in duplicates.
Quantification of soluble collagen protein
Total soluble collagen in cell culture supernatants was quantified using the SirCol collagen assay (Biocolor, Belfast, Northern Ireland) as described. [17] Immunohistochemistry for Jag-1, CD3 and the NICD Fresh frozen sections of forearm skin from SSc patients (n = 13; supplementary Table   3 ) and healthy individuals (n = 10) were used for immunohistochemical analyses (see Supplementary Methods).
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Immunofluorescence for α-smooth muscle actin and the NICD Fibroblasts stimulated with Jag-1-Fc (5 µg/ml) were incubated with monoclonal anti-αSMA antibodies (clone 1A4, Sigma-Aldrich, Steinheim, Germany) and polyclonal rabbitanti-human NICD (Abcam, Cambridge, UK). TRITC conjugated goat anti-mouse antibodies and FITC conjugated goat anti-rabbit antibodies (Invitrogen, Karlsruhe, Germany) served as secondary antibodies. Counterstaining was performed with DAPI (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) for ten minutes at room temperature.
Western Blot
Whole cell lysates were prepared as previously described. 
Statistics
Data are expressed as mean ± standard error of the mean. The Wilcoxon signed rank tests for related samples and the Mann-Whitney-U-test for non-related samples were used for statistical analyses. A p-value of less than 0.05 was considered statistically significant.
Results
Notch signaling is activated in lesional skin of SSc patients
We first analyzed the expression of the four Notch receptors in dermal fibroblasts. The levels of Notch-1 mRNA were significantly increased in SSc fibroblasts as compared to controls (Supplementary Figure 1) . Notch-2 was detectable, but in contrast to Notch-1, its levels did not differ between SSc and controls. Notch-3 and Notch-4 were not detectable by real-time PCR in dermal fibroblasts as these receptors are predominantly expressed in vascular smooth muscle cells and vascular endothelial cells. [19] To investigate whether Notch signaling is activated in lesional skin of SSc patients, we stained for the NICD, which is only released upon ligand binding to Notch and therefore is a marker for activation of the Notch pathway. [3] The NICD was almost undetectable in healthy individuals ( Figure 1a ). In contrast, we observed an intensive staining in all SSc patients, particularly in fibroblasts of the papillary dermis ( Figure 1a) . Staining for the NICD, however, was not restricted to fibroblasts and was also prominent in keratinocytes, endothelial cells, pericytes, vascular smooth muscle cells and T cells as described before (Figure 1a ). [20] Consistent with increased Notch signaling, the mRNA levels of the Notch target gene hes-1 were elevated by 392 ± 33 % in skin biopsies of SSc patients as compared to skin biopsies from healthy individuals (p < 0.05) (Figure 1b) . To investigate the mechanisms that activate Notch signaling in SSc, we analyzed the expression of Notch ligands and observed an upregulation of Jag-1 mRNA levels by 608 ± 86 % in SSc skin compared to control skin samples (p < 0.05) (Figure 1c) . Expression of Jag-1 protein was detected in epidermis and dermis of all SSc patients (Figure 1d) . A prominent expression of Jag-1 was observed in inflammatory infiltrates in fibrotic skin. Double-staining for Jag-1 and CD3 showed elevated Jag-1 expression particularly in T cells (Figure 1e ). In contrast to SSc patients, no significant expression of Jag-1 was detected in healthy individuals. 8 
Persistent activation of the Notch pathway in cultured SSc fibroblasts
Of particular interest, the increased activation of the Notch pathway in dermal SSc fibroblasts persisted in vitro. A significant accumulation of the NICD occurred in SSc fibroblasts, whereas the NICD was barely detectable in fibroblasts from healthy individuals (Figure 2a) . Consistently, the mRNA levels of hes-1 were upregulated in cultured SSc fibroblasts in passages 4 to 8 with increases of 375 ± 50 % compared to fibroblasts from healthy individuals (p < 0.05) (Figure 2b ).
Jag-1 stimulates the release of extracellular matrix
To investigate whether the overexpression of Jag-1 and the increased activation of the Notch pathway contribute to the aberrant production of extracellular matrix, healthy dermal fibroblasts were stimulated with recombinant Jag-1. [21, 22] Activation of the Notch pathway upon stimulation with Jag-1-Fc was confirmed by a dose-dependent increase in hes-1 mRNA levels ( Figure 3a) . Jag-1 upregulated dose-dependently the expression of extracellular matrix components reaching a maximum at concentrations of 5 µg / ml (Figures 3b-d) . Stimulation with Jag-1-Fc increased the mRNA levels of col 1a1 and col 1a2 to 294 ± 37 % and 217 ± 28 %, respectively (p < 0.05) (Figure 3b and 3c) . Consistent with the results on the mRNA level, collagen protein in cell culture supernatants increased to 259 ± 32 % upon stimulation with Jag-1-Fc as assessed by the SirCol assay (p < 0.05) (Figure 3d ).
To discriminate between increased gene transcription and altered mRNA stability in response to stimulation with Jag-1-Fc, we performed mRNA stability and reporter assays. The relative changes in mRNA levels of extracellular matrix proteins did not differ between Jag-1- 
DAPT effectively reduces the stimulatory effects of Jag-1
The activity of γ-secretase is essential for the activation of Notch signaling. To evaluate the effects of the γ-secretase inhibitor DAPT on the release of extracellular matrix, we incubated Jag-1 stimulated healthy dermal fibroblasts with DAPT at pharmacologically relevant concentrations. [23, 24] DAPT inhibited the mRNA expression of col 1a1 in healthy dermal fibroblasts stimulated with Jag-1-Fc dose-dependently by up to 99 ± 23 % (p < 0.05) (supplementary Figure 3a) . Similar effects were obtained for col 1a2 (p < 0.05) (supplementary Figure 3b) . Consistent with reduced mRNA levels, the release of collagen protein was reduced by 94 ± 34 % upon pretreatment with DAPT (p < 0.05) (supplementary Figure 3c ).
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Inhibition of Notch signaling reduces the basal collagen synthesis specifically in SSc fibroblasts
We demonstrated a persistent activation of the Notch pathway in cultured fibroblasts from SSc patients. To assess whether inhibition of the Notch pathway can inhibit the basal release of collagen, SSc fibroblasts were incubated with DAPT in the absence of Jag-1-Fc.
Treatment of unstimulated SSc fibroblasts with DAPT reduced the mRNA levels of col 1a1 and col 1a2 by up to 49 ± 9 % and 41 ± 6 %, respectively (p < 0.05 for both) (Figure 5a To exclude off-target effects, we confirmed the anti-fibrotic effects of DAPT signaling by transfection of SSc fibroblasts with siRNA against Notch-1 which resulted in significantly decreased mRNA and protein levels of Notch-1 (p < 0.05) (Figure 6a) . Knockdown of Notch-1 efficiently reduced mRNA levels of col 1a1 and col 1a2 by 58 ± 11 % and 48 ± 9 % compared to mock transfected SSc fibroblasts (Figure 6b and c) . Consistently, the release of collagen protein was reduced by 42 ± 8 % (p < 0.05) upon silencing of Notch-1 (Figure 6d ).
Discussion
We demonstrate in the present study that Notch signaling is activated in SSc with a prominent expression of the ligand Jag-1 in infiltrating T cells and active Notch signaling with accumulation of the NICD in fibroblasts. We further showed that the activation of Notch signaling has major implications on the activation of fibroblasts. The expression patterns of Jag-1 and the NICD suggest that infiltrating T cells expressing Jag-1 might activate Notch signaling in resident fibroblasts. Jag-1 is prominently expressed in T cells in fibrotic skin. Figure 3a) , col 1a1 (Figure 3b ) and col 1a2 (Figure 3c ) in a dosedependent manner. Consistently, Jag-1 stimulated the release of collagen protein (Figure 3d) (n = 8 each). * indicates statistical significant differences compared to unstimulated fibroblasts. 
